G-Rex® Grant Program by ScaleReady

The G-Rex® Grant Program is a $20 million initiative by ScaleReady, Wilson Wolf Manufacturing, Bio-Techne, and CellReady, that is designed to advance the state of cell and gene therapy (CGT) manufacturing. Specifically, the program offers CGT developers the expertise, tools, and technologies needed to defray the time and cost associated with achieving organizational milestones and inflection points in a G-Rex centric platform. 

The G-Rex® Grant program provides academic and commercial institutions with up to $300,000 of critical support to overcome challenges in the development of cell and gene-modified cell therapies. Institutions can establish an optimized manufacturing process, ensuring faster and more cost-effective translation of cell and gene therapies into the clinic. For more information go to scaleready.com/g-rex-grant-program.

Synthego is proud to partner with the G-Rex® Grant Program, offering exclusive discounts to grant awardees to further reduce costs and maximize the accessibility of critical resources. This partnership underscores Synthego’s commitment to advancing cell and gene therapy innovation across all stages of therapeutic development. If you are a G-Rex® Grant awardee or applicant,  reach out to us  to explore your exclusive benefits with Synthego.